These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 20430300

  • 1. Psoriasis and Biologics. Introduction.
    Leonardi C.
    Semin Cutan Med Surg; 2010 Mar; 29(1):1-2. PubMed ID: 20430300
    [No Abstract] [Full Text] [Related]

  • 2. [New therapy option for problem patients. What is the value of "biologics" in psoriasis?].
    Boehncke WH.
    MMW Fortschr Med; 2004 Nov 11; 146(46):45. PubMed ID: 15600044
    [No Abstract] [Full Text] [Related]

  • 3. The role of biologics and other systemic agents in the treatment of pediatric psoriasis.
    Wright NA, Piggott CD, Eichenfield LF.
    Semin Cutan Med Surg; 2010 Mar 11; 29(1):20-7. PubMed ID: 20430304
    [No Abstract] [Full Text] [Related]

  • 4. [Chronic inflammatory diseases. Early biologics therapy is cost effective].
    MMW Fortschr Med; 2010 May 27; 152(21):78-9. PubMed ID: 20608134
    [No Abstract] [Full Text] [Related]

  • 5. The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics.
    Driessen RJ, Bisschops LA, Adang EM, Evers AW, Van De Kerkhof PC, De Jong EM.
    Br J Dermatol; 2010 Jun 27; 162(6):1324-9. PubMed ID: 20163420
    [Abstract] [Full Text] [Related]

  • 6. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
    Levine D, Strober BE.
    Semin Cutan Med Surg; 2010 Mar 27; 29(1):28-34. PubMed ID: 20430305
    [Abstract] [Full Text] [Related]

  • 7. Combining traditional systemic and biologic therapies for psoriasis.
    Heffernan MP.
    Semin Cutan Med Surg; 2010 Mar 27; 29(1):67-9. PubMed ID: 20430311
    [Abstract] [Full Text] [Related]

  • 8. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.
    Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, Strober B, Van Voorhees A, Weinstein GD, Young M, Horn L.
    J Am Acad Dermatol; 2008 Jan 27; 58(1):94-105. PubMed ID: 17980456
    [Abstract] [Full Text] [Related]

  • 9. The relevance of biologics for the treatment of patients with psoriasis.
    van de Kerkhof PC.
    Br J Dermatol; 2009 Dec 27; 161(6):1213-4. PubMed ID: 19941484
    [No Abstract] [Full Text] [Related]

  • 10. Do utilization management controls for phototherapy increase the prescription of biologics?
    Simpson GL, Yelverton CB, Rittenberg S, Feldman SR.
    J Dermatolog Treat; 2006 Dec 27; 17(6):359-61. PubMed ID: 17853310
    [Abstract] [Full Text] [Related]

  • 11. [Psoriasis. How much promise for immunobiologic therapy?].
    Musch A.
    Med Monatsschr Pharm; 2005 Aug 27; 28(8):262-6. PubMed ID: 16128537
    [No Abstract] [Full Text] [Related]

  • 12. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J, Kerdel F.
    Dermatol Ther; 2008 Aug 27; 21(2):131-41. PubMed ID: 18394087
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
    Stiefelhagen P.
    MMW Fortschr Med; 2007 Sep 06; 149(35-36):12-4. PubMed ID: 17944277
    [No Abstract] [Full Text] [Related]

  • 14. [Targeted against T-cells: immunomodulators in psoriasis].
    Mader U.
    Dtsch Med Wochenschr; 2003 Aug 01; 128(31-32):1640. PubMed ID: 12931726
    [No Abstract] [Full Text] [Related]

  • 15. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
    Bhosle MJ, Feldman SR, Camacho FT, Timothy Whitmire J, Nahata MC, Balkrishnan R.
    J Dermatolog Treat; 2006 Aug 01; 17(5):294-301. PubMed ID: 17092860
    [Abstract] [Full Text] [Related]

  • 16. Current biologic treatments for psoriasis.
    Gottlieb AB, Kardos M, Yee M.
    Dermatol Nurs; 2009 Aug 01; 21(5):259-66, 272; quiz 267. PubMed ID: 19873691
    [Abstract] [Full Text] [Related]

  • 17. PASI 75.
    Rapaport MJ.
    J Am Acad Dermatol; 2005 Jan 01; 52(1):183-4; author reply 184-5. PubMed ID: 15627120
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of plaque psoriasis by sequential therapy with two 'biologics': the 'hit and run' approach, a report of two cases.
    Barde C, Thielen AM, Kuenzli S, Saurat JH.
    Br J Dermatol; 2006 Jul 01; 155(1):211-3. PubMed ID: 16792780
    [No Abstract] [Full Text] [Related]

  • 19. Care of patients with psoriasis: an audit of U.K. services in secondary care.
    Eedy DJ, Griffiths CE, Chalmers RJ, Ormerod AD, Smith CH, Barker JN, Potter J, Ingham J, Lowe D, Burge S.
    Br J Dermatol; 2009 Mar 01; 160(3):557-64. PubMed ID: 19120330
    [Abstract] [Full Text] [Related]

  • 20. Biologics in nail psoriasis: a new trend in treatment?
    Rigopoulos D.
    J Eur Acad Dermatol Venereol; 2019 Nov 01; 33(11):2014-2015. PubMed ID: 31713913
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.